Kurt A. Gustafson
2010 - Halozyme Therapeutics
In 2010, Kurt A. Gustafson earned a total compensation of $489.8K as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $78,875 |
|---|---|
| Option Awards | $93,260 |
| Salary | $310,000 |
| Other | $7,662 |
| Total | $489,797 |
Gustafson received $310K in salary, accounting for 63% of the total pay in 2010.
Gustafson also received $78.9K in non-equity incentive plan, $93.3K in option awards and $7.7K in other compensation.
Rankings
In 2010, Kurt A. Gustafson's compensation ranked 7,781st out of 10,439 executives tracked by ExecPay. In other words, Gustafson earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,781 out of 10,439 | 26th |
Division Manufacturing | 2,891 out of 3,838 | 25th |
Major group Chemicals And Allied Products | 688 out of 921 | 25th |
Industry group Drugs | 475 out of 680 | 30th |
Industry Biological Products, Except Diagnostic Substances | 91 out of 142 | 36th |
Source: SEC filing on April 11, 2013.
Gustafson's colleagues
We found seven more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2010
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2010
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019